SCHEDULE 14A
(RULE 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. 1)
Filed by the Registrant [X]
Filed by a Party other than the Registrant [_]
Check the appropriate box:
[X] Preliminary Proxy Statement [_] Confidential, For Use of the
Commission Only (As Permitted by
[_] Definitive Proxy Statement Rule 14a-6(e)(2))
[_] Definitive Additional Materials
[_] Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12
AIRTRAX, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
[_] Fee paid previously with preliminary materials.
[_] Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the form or schedule and the date of its filing.
(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
AIRTRAX, INC.
870B Central Avenue
Hammonton, New Jersey 08037
March__, 2005
Dear Stockholder,
You are cordially invited to attend a Special Meeting of Stockholders (the
"Meeting") of Airtrax, Inc. (the "Company"). The Meeting will be held on March
28, 2005 at 9:30 a.m. local time, at the Ramada Inn, 2216 West Landis Avenue,
Vineland, New Jersey 08360.
The Notice of the Meeting and the Proxy Statement on the following pages cover
the formal business of the Meeting. We also will report on the progress of the
Company and comment on matters of current interest.
It is important that your shares be represented at the Meeting. We ask that you
promptly sign, date and return the enclosed proxy card in the envelope provided,
even if you plan to attend the Meeting. Returning your proxy card to the Company
will not prevent you from voting in person at the Meeting if you are present and
choose to do so.
If your shares are held in street name by a brokerage firm, your broker will
supply you with a proxy to be returned to the brokerage firm. It is important
that you return the form to the brokerage firm as quickly as possible so that
the brokerage firm may vote your shares. You may not vote your shares in person
at the Meeting unless you obtain a power of attorney or legal proxy from your
broker authorizing you to vote the shares, and you present this power of
attorney or proxy at the Meeting.
Your Board of Directors and management look forward to greeting you personally
at the Meeting.
Sincerely,
/s/ Peter Amico
---------------
Peter Amico
Chief Executive Officer and Chairman
of the Board of Directors
2
AIRTRAX, INC.
870B Central Avenue
Hammonton, New Jersey 08037
NOTICE OF A SPECIAL MEETING OF STOCKHOLDERS
MONDAY, MARCH 28, 2005
Notice is hereby given that a Special Meeting of Stockholders of Airtrax, Inc.
(the "Company"), a New Jersey corporation, will be held on March 28, 2005 at
9:30 a.m. local time, at the Ramada Inn, 2216 West Landis Avenue, Vineland, New
Jersey 08360, for the following purposes:
1. To approve an amendment to the Company's certificate of incorporation to
increase the number of authorized shares of common stock, no par value per share
(the "Common Stock") of the Company from 20,000,000 shares to 100,000,000
shares; and
2. To approve an amendment to the Company's certificate of incorporation to
increase the authorized shares of the Company's "blank check" preferred stock
from 500,000 to 5,000,000 shares; and
3. To approve an amendment to the Company's certificate of incorporation to
provide, to the fullest extent permitted by New Jersey law, that the Company's
directors or officers shall not be personally liable to the Company or its
shareholders for damages for breach of such director's or officer's fiduciary
duty; and
4. To transact such other business as may properly come before the Meeting or
any adjournment thereof.
Your attention is directed to the Proxy Statement accompanying this Notice for a
more complete description of the matters to be acted upon at the Meeting. The
2003 Annual Report of the Company is also enclosed. Stockholders of record at
the close of business on Wednesday, February 16, 2005 are entitled to receive
notice of and to vote at the Meeting and any adjournment thereof.
All stockholders are cordially invited to attend the Meeting. Whether or not you
expect to attend, please sign and return the enclosed Proxy promptly in the
envelope provided to assure the presence of a quorum. You may revoke your Proxy
and vote in person at the Meeting, if you so desire. If your shares are held in
street name by a brokerage firm, your broker will supply you with a proxy to be
returned to the brokerage firm. It is important that you return the form to the
brokerage firm as quickly as possible so that the brokerage firm may vote your
shares. You may not vote your shares in person at the Meeting unless you obtain
a power of attorney or legal proxy from your broker authorizing you to vote the
shares, and you present this power of attorney or proxy at the Meeting.
Please note that attendance at the Meeting will be limited to stockholders of
the Company as of the record date (or their duly authorized representatives). If
your shares are held by a bank or broker, please bring to the Meeting your bank
or brokerage statement evidencing your beneficial ownership of the Company
stock.
By Order of the Board of Directors,
/s/ Peter Amico
---------------
Peter Amico
Chief Executive Officer and Chairman
of the Board of Directors
Hammonton, New Jersey
March __, 2005
3
AIRTRAX, INC.
870B Central Avenue
Hammonton, New Jersey 08037
PROXY STATEMENT
This Proxy Statement is furnished by the Board of Directors and management of
Airtrax, Inc. (the "Company") in connection with the solicitation of proxies to
be voted at the Company's Special Meeting of Stockholders (the "Meeting"), which
will be held on March 28, 2005 at 9:30 a.m. local time, at the Ramada Inn, 2216
West Landis Avenue, Vineland, New Jersey 08360
The Board of Directors has fixed the close of business on Wednesday, February
16, 2005 as the record date (the "Record Date") for the determination of
stockholders entitled to receive notice of, and to vote at, the Meeting. As of
Wednesday, February 16, 2005, 15,387,092 shares of the Company's common stock,
no par value, were issued and outstanding. For the purposes of determining the
presence of a quorum at the Meeting, abstentions will be counted toward the
number of shares represented at the Meeting and broker non-votes will be
disregarded. The stockholders present at the Meeting may continue to transact
business until adjournment, notwithstanding the subsequent withdrawal of enough
stockholders to leave less than a quorum or the refusal of any stockholder
present in person or by proxy to vote or participate in the Meeting.
This Proxy Statement and the enclosed form of proxy are first being mailed to
stockholders on or about March __, 2005. All shares represented by valid proxies
pursuant to this solicitation (and not revoked before they are exercised) will
be voted as specified in the proxy. Each stockholder will be entitled to one
vote for each share of Common Stock registered in his or her name on the books
of the Company as of the close of business on February 16, 2005, on all matters
that come before the Meeting.
For purposes of determining the votes cast with respect to any matter presented
for consideration at the Meeting, only those votes cast "for" or "against" are
included. However, if a proxy is signed but no specification is given, the
shares will be voted "FOR" Proposal 1 (to elect the Board's nominees to the
Board of Directors). A stockholder giving a proxy has the right to revoke it by
giving written notice of such revocation to the Secretary of the Company at any
time before it is voted, by submitting to the Company a duly executed, later
dated proxy or by voting the shares subject to such proxy by written ballot at
the Meeting. The presence at the Meeting of a stockholder who has given a proxy
does not revoke such proxy unless such stockholder files the aforementioned
notice of revocation or votes by written ballot.
Determination of whether a matter specified in the Notice of a Special Meeting
of Stockholders has been approved will be determined as follows. For proposals
1, 2, and 3 to amend the Company's Certificate of Incorporation, the affirmative
vote of a majority of all shares of Common Stock outstanding is required. For
each other matter, the affirmative vote of a majority of the shares of Common
Stock present at the Meeting in person or by proxy and entitled to vote on such
matter is required for approval.
For purposes of determining the votes cast with respect to any matter presented
for consideration at the Meeting, only those votes cast "for" or "against" are
included. However, if a proxy is signed but no specification is given, the
shares will be voted "FOR" Proposals 1, 2 and 3. A stockholder giving a proxy
has the right to revoke it by giving written notice of such revocation to the
Secretary of the Company at any time before it is voted, by submitting to the
Company a duly executed, later dated proxy or by voting the shares subject to
such proxy by written ballot at the Meeting. The presence at the Meeting of a
stockholder who has given a proxy does not revoke such proxy unless such
stockholder files the aforementioned notice of revocation or votes by written
ballot.
The cost of soliciting proxies will be borne by the Company. The solicitation of
proxies may be made by mail, telephone, facsimile or telegraph or in person by
directors, officers and regular employees of the Company, without additional
compensation for such services. Arrangements will be made with brokerage houses
and other custodians, nominees and fiduciaries to forward proxy soliciting
material to the beneficial owners of stock held of record by such persons, and
the Company will reimburse them for reasonable out of pocket expenses incurred
in so doing.
1. AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO INCREASE AUTHORIZED COMMON
STOCK
The board of directors has adopted, subject to stockholder approval, an
amendment to our certificate of incorporation to increase the number of
authorized shares of Common Stock from 20,000,000 to 100,000,000. The Company
4
currently has authorized capital stock of 20,000,000 shares and approximately
15,387,092 shares of Common Stock are outstanding as of the Record Date.
Between September 8, 2004 and the date hereof, we have entered into several
financing agreements that require an issuance of shares greater than the number
of shares that the Company is currently authorized to issue. By entering into
these agreements, the Company has exhausted its 20,000,000 authorized shares of
Common Stock and cannot meet any equity and/or convertible debt-based
obligations entered into after September 2004 without stockholder approval for
an increase in the number of authorized shares. Specifically, the Company has
completed the following financing transactions:
o On February 11, 2005, the Company entered into a Subscription
Agreement with certain accredited investors pursuant to which the
Company sold an aggregate of $5,000,000 of principal amount promissory
notes which are convertible into an aggregate of 3,846,154 shares of
Common Stock and Class A and B warrants to purchase an aggregate of
2,884,615 shares of Common Stock.
o In addition, the Company entered into a Securities Purchase Agreement
with certain accredited investors on November 22 and 23, 2004 pursuant
to which the Company issued warrants to purchase an aggregate of
984,000 shares of Common Stock.
o Between September 8, 2004 and December 20, 2004, the Company received
subscriptions for an aggregate of 1,812,403 shares of Common Stock and
an aggregate of 906,200 shares of Common Stock issuable upon exercise
of common stock purchase warrants to 33 accredited investors pursuant
to a private placement offering.
In addition to the foregoing, the Company has the following convertible
securities outstanding:
o Warrants to purchase 100,000 shares of Common Stock which were issued
pursuant to an Advisory Agreement dated as of September 20, 2004.
o Options to purchase an aggregate of 1,000,000 shares of Common Stock
issued to Fil Filipov in connection with the proposed acquisition of
Filco GmbH and in consideration for Mr. Filipov's services as a
director of the Company.
o Warrants to purchase an aggregate of 2,615,375 shares of Common Stock
exercisable at $1.25 per share.
o Warrants to purchase an aggregate of 865,000 shares of Common Stock
exercisable at $2.50 per share
Based upon the foregoing, the Company will need a total of approximately
15,013,747 shares of Common Stock in order to be able to honor these various
obligations, greater than the number of shares that the Company is currently
authorized to issue. Unless the Company's stockholders approve this Proposal 1,
the Company will be unable to perform its obligations under the equity and/or
convertible debt-based agreements and will be in default pursuant to the terms
of the agreements. Management of the Company believes that it is highly likely
that such default will require the Company to substantially curtail or cease its
operations, and may result in a total loss of the your investment in the
Company. The Company intends to utilize the additional shares of authorized
Common Stock in order to meet its obligations pursuant to the aforementioned
equity and/or convertible debt-based financings and to have sufficient shares of
Common Stock available with respect to the Company's outstanding convertible
securities. In addition, the board of directors believes that the increase in
authorized Common Stock would provide the Company greater flexibility with
respect to the Company's capital structure for such purposes as additional
equity financing, and stock based acquisitions. Notwithstanding the
aforementioned, the Company has no present intentions to issue any of the newly
authorized shares of common stock.
The amendment to the first paragraph of Section 5 of our certificate of
incorporation with respect to this Proposal 1 shall read as follows:
"5. The aggregate number of shares which the corporation shall have the
authority to issue is one-hundred five million (105,000,000), itemized by
classes, par value of shares, shares without par value, and series, if any,
within a class, is:
5
Par value per Share or
statement that Shares
Class Series (if any) Number of Shares have no par value
----- -------------- ---------------- -----------------------
Common 100,000,000 No par
Preferred 5,000,000 No par"
The terms of the additional shares of Common Stock will be identical to those of
the currently outstanding shares of Common Stock. However, because holders of
Common Stock have no preemptive rights to purchase or subscribe for any unissued
stock of the Company, the issuance of additional shares of Common Stock will
reduce the current stockholders' percentage ownership interest in the total
outstanding shares of Common Stock. This amendment and the creation of
additional shares of authorized common stock will not alter the current number
of issued shares. The relative rights and limitations of the shares of Common
Stock will remain unchanged under this amendment.
The increase in the number of authorized but unissued shares of Common Stock
would enable the Company, without further stockholder approval, to issue shares
from time to time as may be required for proper business purposes, such as
raising additional capital for ongoing operations, business and asset
acquisitions, stock splits and dividends, present and future employee benefit
programs and other corporate purposes.
The proposed increase in the authorized number of shares of Common Stock could
have a number of effects on the Company's stockholders depending upon the exact
nature and circumstances of any actual issuances of authorized but unissued
shares. The increase could have an anti-takeover effect, in that additional
shares could be issued (within the limits imposed by applicable law) in one or
more transactions that could make a change in control or takeover of the Company
more difficult. For example, additional shares could be issued by the Company so
as to dilute the stock ownership or voting rights of persons seeking to obtain
control of the Company. Similarly, the issuance of additional shares to certain
persons allied with the Company's management could have the effect of making it
more difficult to remove the Company's current management by diluting the stock
ownership or voting rights of persons seeking to cause such removal. The board
of directors is not aware of any attempt, or contemplated attempt, to acquire
control of the Company, and this proposal is not being presented with the intent
that it be utilized as a type of anti- takeover device.
The board of directors recommends a vote " FOR " the proposals to amend our
certificate of incorporation to increase the number of authorized shares of
Common Stock from 20,000,000 to 100,000,000.
2. AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED
SHARES OF COMPANY'S "BLANK CHECK" PREFERRED STOCK TO 5,000,000 SHARES
The board of directors has adopted, subject to stockholder approval, an
amendment to our certificate of incorporation to increase the number of
authorized shares of "blank check" preferred stock from 500,000 to 5,000,000.
Pursuant to the laws of the State of New Jersey and the Company's certificate of
incorporation, the Company's board of directors will have the authority, without
further action by our stockholders, to issue up to 500,000 shares of preferred
stock in one or more series and to fix the privileges and rights of each series.
The Company's board of directors is now requesting that the stockholders approve
an increase in the number of shares of "blank check" preferred stock which the
Company can issue from 500,000 to 5,000,000. Currently, the Company has 275,000
shares of preferred stock outstanding which was issued to Arcon Corp., a
corporation wholly owned by the Company's chairman and president, Peter Amico.
In addition, the Company intends to issue an additional 100,000 shares of
preferred stock to Arcon Corp. in lieu of approximately 221,000 shares of Common
Stock as payment for accrued dividends with respect to the 275,000 shares of
preferred stock. The Company believes that said issuance of 100,000 shares of
preferred stock is in the best interests of its shareholders because the payment
of accrued dividends in the form of Common Stock may result in substantial
dilution to the interests of its common stockholders. Notwithstanding the
aforementioned, the Company has no present intentions to issue any of the newly
authorized shares of preferred stock.
The board of directors believes that increasing the number of authorized but
unissued shares of preferred stock will provide the board with further
flexibility to raise capital and to protect the Company against unsolicited
takeover attempts. However, when designating and issuing the preferred stock,
the board of directors may issue shares with voting, conversion or other rights
that could adversely affect the voting power and other rights of the common
stockholders. Further, this type of "blank check preferred stock" makes it
possible for the Company to issue preferred stock quickly with terms calculated
to delay or prevent a change in the Company's control or make removal of the
Company's management more difficult. Additionally, if the Company issues the
preferred stock, the market price of common stock may decrease, and voting and
other rights may decrease.
The amendment to Section 5 of the Company's certificate of incorporation with
respect to this Proposal 2 shall read as follows:
6
"5. The aggregate number of shares which the corporation shall have the
authority to issue is fifty five million (55,000,000), itemized by classes, par
value of shares, shares without par value, and series, if any, within a class,
is:
Par value per Share or
statement that Shares
Class Series (if any) Number of Shares have no par value
----- --------------- ---------------- ----------------------
Common 100,000,000 No par
Preferred 5,000,000 No par
The relative rights, preferences and limitations of the shares of each class and
series (if any), are as follows:
The preferred stock, or any series thereof, shall have such designations,
preferences and relative, participating, optional or other special rights and
qualifications, limitations or restrictions thereof as shall be expressed in the
resolution or resolutions providing for the issue of such stock adopted by the
Board of Directors and may be made dependent upon facts ascertainable outside
such resolution or resolutions of the Board of Directors, provided that the
matter in which such facts shall operate upon such designations, preferences,
rights and qualifications; limitations or restrictions of such class or series
of stock is clearly and expressly set forth in the resolution or resolutions
providing for the issuance of such stock by the Board of Directors."
The board of directors recommends a vote " FOR " the proposals to amend the
Company's certificate of incorporation to increase the number of authorized
shares of "blank check" preferred stock from 500,000 to 5,000,000.
3. AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO PROVIDE THAT THE COMPANY MAY
INDEMNIFY ITS OFFICERS AND DIRECTORS
The board of directors has adopted, subject to stockholder approval, an
amendment to the Company's certificate of incorporation which will provide to
the fullest extent permitted by New Jersey law, that the Company's directors or
officers shall not be personally liable to the Company or its shareholders for
damages for breach of such director's or officer's fiduciary duty. The effect of
this provision of the amendment to the Company's certificate of incorporation is
to eliminate the Company's rights and its shareholders rights (through
shareholders' derivative suits on behalf of the Company) to recover damages
against a director or officer for breach of the fiduciary duty of care as a
director or officer (including breaches resulting from negligent or grossly
negligent behavior), except under certain situations defined by statute. The
board of directors believes that the indemnification provisions in the Company's
certificate of incorporation are necessary to attract and retain qualified
persons as directors and officers.
Insofar as indemnification for liabilities arising under the Securities Act of
1933 (the "Act" or "Securities Act") may be permitted to directors, officers or
persons controlling us pursuant to the foregoing provisions, or otherwise, the
Company has been advised that in the opinion of the Securities and Exchange
Commission, such indemnification is against public policy as expressed in the
Act and is, therefore, unenforceable.
The board of directors recommends a vote " FOR " the proposals to amend the
Company's certificate of incorporation to provide to the fullest extent
permitted by New Jersey law, that the Company's directors or officers shall not
be personally liable to the Company or its shareholders for damages for breach
of such director's or officer's fiduciary duty.
4. OTHER BUSINESS
The Board of Directors knows of no other matters which are likely to be brought
before the Meeting. If any matter not described herein should be presented for
Stockholder action at the Meeting, the persons named in the enclosed Proxy will
vote the shares represented thereby in accordance with their best judgment.
7
MANAGEMENT
Directors are elected at each meeting of stockholders and hold office until the
next annual meeting of stockholders and the election and qualifications of their
successors. Executive officers are elected by and serve at the discretion of the
board of directors.
Our executive officers and directors are as follows:
Name Age Position
---- --- --------
Peter Amico 61 President and Chairman of the Board of Directors
D. Barney Harris 43 Executive Vice President and Director
Frank A. Basile, Esq 68 Director
James Hudson 61 Director
William Hungerville 68 Director
Fil Filipov 58 Director
Peter Amico - Mr. Amico is the founder of the Company and has been President and
Chairman of the Company and its predecessor since their inception in April 1995.
Prior to 1995, Mr. Amico was president and majority shareholder of Titan
Aviation and Helicopter Services, Inc. ("Titan"). He has an extensive background
in sales and in structural steel design. His career in sales has spanned over
thirty years and he has held sales positions at Firestone Tire & Rubber and
Union Steel Products, Inc. As a consequence of separate helicopter and airplane
accidents involving Titan, Mr. Amico filed for bankruptcy protection in 1996.
D. Barney Harris - Mr. Harris has been a Director of the Company since December
1998 and a Vice President since July 1999. From 1997 to July 1999, Mr. Harris
was employed by UTD, Inc. Manassas, Virginia. Prior to 1997, Mr. Harris was
employed by EG&G WASC, Inc., Gaithersburg, Maryland, as a Senior Engineer and
Manager of the Ocean Systems Department where he was responsible for the
activities of 45 scientists, engineers and technicians. During this period while
performing contract services for the US Navy, he was principally responsible for
the design of the omni-directional wheel presently used by the Company. Mr.
Harris received his B.S.M.E. from the United States Merchants Marine Academy in
1982.
Fil Filipov - Mr. Filipov is the Chairman of Supervisory Board of Tatra, a Czech
Company, which is producing off highway trucks. He is the former President & CEO
of Terex Cranes, a Division of Terex Corp. From 1994 through 1996, Mr. Filipov
served as Executive Vice President of the Terex Corp., where he was responsible
for strategic acquisitions and was the Managing Director of Clark Material
Handling Company in Germany (Filco GmbH). If the acquisition of Filco GmbH is
completed Mr. Filipov will retain 24.9% of Filco GmbH.
James Hudson - Mr. Hudson has been a Director of the Company since May 1998.
From 1980 to present, he has been President of Grammer, Dempsey & Hudson, Inc.,
a steel distributor located in Newark, New Jersey.
Frank A. Basile, Esq. - Mr. Basile has been a Director of the Company since
April 1999. Mr. Basile has been a practicing attorney since 1963 and is
president of the law firm Basile & Testa, Vineland, New Jersey.
William Hungerville - Mr. Hungerville has been a director since February 2002.
Since 1998, Mr. Hungerville has been retired from full time employment. From
1974 to 1998, he was the sole owner of a pension administrative service firm.
Mr. Hungerville is a graduate of Boston College, and attended an MBA program at
Harvard University for 2 years.
COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT
During the fiscal year ended December 31, 2004, based upon an examination of the
public filings, all of our company's officers and directors timely filed reports
on Forms 3, 4 and 5.
8
EXECUTIVE COMPENSATION
The following table sets forth for the fiscal year indicated the compensation
paid by our company to our Chief Executive Officer and other executive officers
with annual compensation exceeding $100,000:
Summary Compensation Table:
SUMMARY COMPENSATION TABLE
ANNUAL COMPENSATION
Other
Annual Restricted Options LTIP
Name & Principal Salary Bonus Compen- Stock SARs Payouts All Other
Position Year ($) ($) sation ($) Awards($) (#) ($) Compensation
------------------------ ------- ------------ ------------ ------------ ------------- ----------- ------------ --------------
Peter Amico 2004 116,826(1) 0 237,500(3) - - - -
President and Chairman 2003 88,462(1) 0 64,000(2) - - - -
of the Board of Directors 2002 84,135(1) 0 51,399(2) - - - -
------------------------ ------- ------------ ------------ ------------ ------------- ----------- ------------ --------------
(1) During 2004, Mr. Amico was entitled to receive a salary of $185,000, however
$116, 825.62 was paid and the balance was deferred for future payment. During
2003, Mr. Amico was entitled to receive a salary of $100,000, however $88,461.68
was paid and the balance was deferred for future payment. In 2002, $84,135 was
paid as salary to Mr. Amico and $3,365 balance deferred for future payment. In
2002 and 2003, Mr. Amico received the use of a company automobile which the
Company valued at $1,000.
(2) Pursuant to his employment agreement for the year 2004 through 2005, Mr.
Amico had outstanding options to acquire a total of 500,000 shares at a total
price of $0.85 per share. Pursuant to his employment agreement for the year 2003
through 2004, Mr. Amico had outstanding options to acquire a total of 50,000
shares at a total price of $0.01. Pursuant to previous employment agreements,
Mr. Amico had outstanding options to acquire a total of 180,000 shares of common
stock of the Company. Of these options, 20,000 shares wee exercised at a total
price of $2.00, 50,000 shares were exercised at $0.315 per share, 60,000 shares
wee exercised at a price of $0.1575 per share, and 50,000 shares were exercised
at a total price of $0.01. On February 12, 2003, Mr. Amico exercised all of his
options in exchange for the payment of $25,202. The fair market value of the
underlying common stock was $1.26 per share, on the close of business on the
exercise date of February 12, 2003. The amount for 2003 represents the number of
options (50,000) multiplied by the fair market ($1.26) less his exercise costs
of $0.01. The amount for 2002 represents the number of options (50,000)
multiplied by the fair market ($1.26) less his exercise costs of $12,601. The
amount for 2001 represents the number of options (50,000) multiplied by the fair
market ($1.26) less his exercise costs of $12,601. In addition, for 2002 and
2003, the amounts include $1,000 for the value of an automobile usage.
(3) The value for the year 2004 is based upon statements of financial accounting
standards no. 123 and 148, which became a mandatory method for valuing options
in 2004.
EMPLOYMENT AGREEMENTS
The Company and Peter Amico have entered into written employment agreements for
Mr. Amico's role as President of the Company. The parties entered into an
agreement covering the period from April 1997 to June 30, 2002 ("Original
Employment Agreement"). Effective July 1, 2002, the parties entered into a
second employment agreement for a one year term ("Second Employment Agreement").
Agreements for the year 2003 through 2004 and 2004 through 2006 were agreed to
on November30, 2004.
Under the Original Employment Agreement, Mr. Amico received an annual salary of
$75,000 per year, and received stock options to acquire up to 50,000 shares per
annum. Of the options, 10,000 shares were exercisable for a total consideration
of a $1.00 beginning in year three of the contract, 25,000 shares were
exercisable at 30% of the lowest price paid for the stock in the 30 day period
preceding such exercise for each year of the contract, and 15,000 shares were
exercisable at 15% of the lowest price paid for the stock in the 30 day period
preceding such exercise beginning in year three of the contract.
Under the Second Employment Agreement, Mr. Amico was entitled to receive an
annual salary of $100,000, and receive an option to acquire 50,000 shares of
common stock of the Company for a total exercise price of $0.01. The Company may
terminate the agreement without cause upon 14 days' written notice to the
Employee.
Under the Employment Agreement, ratified by the Board of Directors on November
30, 2004 for the period of July, 1 2003 through June 30, 2004, Mr. Amico was
entitled to receive an annual salary of $135,000, and receive an option to
acquire 50,000 shares of our common stock for a total exercise price of $0.01.
We may terminate the agreement without cause upon 14 days' written notice to the
Mr. Amico.
Under a two year Employment Agreement, ratified by the Board of Directors on
November 30, 2004 for the period of July 1, 2004 through June 30, 2005, Mr.
9
Amico is entitled to receive an annual salary of $200,000, and receives options
to purchase up to 500,000 shares of our common stock per year at a rate equal to
the "bid" price of the stock per share on the beginning date of the employment
agreement. All options have a cashless exercise. We may terminate the agreement
without cause upon 14 days' written notice to Mr. Amico. Under the second year
of the above Employment Agreement, for the period of July 1, 2005 through June
30,2006, Mr. Amico is entitled to receive an annual salary of $250,000, and
options to purchase up to 750,000 shares of our common stock per year at the
rate equal to the "bid" price of the stock per share on the beginning date of
the employment agreement. All options have a cashless exercise. We may terminate
the agreement without cause upon 14 days' written notice to Mr. Amico.
DIRECTORS' COMPENSATION
The Company's directors are compensated at the rate of $250 per meeting and are
reimbursed for expenses incurred by them in connection with the Company's
business. During 2002 and 2001, each director, other than Mr. Amico, received an
annual stock option to purchase 5,000 shares of common stock exercisable at
$0.50 per share. During 2003, each director received a stock grant of 10,000
shares of the Company's common stock. During 2004, each director received a
stock grant of 10,000 shares of the Company's common stock. The Company's board
of directors approved a stock grant in the amount of 20,000 shares of common
stock for its board of directors for 2005, conditional upon the Company having
revenues.
Other than as described above, the Company does not have any other form of
compensation payable to its officers or directors, including any stock option
plans, stock appreciation rights, or long term incentive plan awards for the
periods indicated in the table. The Company will approve compensation to Board
members serving on the Audit Committee of the Company during the next scheduled
Board meeting.
OPTION GRANTS IN LAST FISCAL YEAR
The following table contains information concerning options granted to executive
officers named in the Summary Compensation Table during the fiscal year ended
December 31, 2004:
Individual Grants
Number of % of Total Options
Securities Granted to
Name Underlying Employees in Fiscal
Options Granted Year Exercise Expiration Date
(#) Price ($/sh)
--------- ----------------------------------------------------------------------------
Peter Amico 50,000 8% (1) $ -(1) None(1)
President and Chairman 500,000 83%(1) $.85 (1) None(1)
(1) Pursuant to his employment agreement for the year 2004 through 2005, Mr.
Amico has outstanding options to acquire a total of 500,000 shares at a total
price of $0.85 per share. Pursuant to his employment agreement for the year 2003
through 2004, Mr. Amico has outstanding options to acquire a total of 50,000
shares at a total price of $0.01.
OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR-END OPTION VALUES
The following table contains information concerning the number and value, at
December 31, 2004, of unexercised options held by executive officers named in
the Summary Compensation Table:
10
Number of Securities Underlying Unexercised Options at Value of Unexercised In-the-Money
Name FY-End (#) (Exercisable/Unexercisable) Options at FY-End ($)
(Exercisable/Unexercisable)
------- ------------------------------------------------------------------------------------------------------
Peter Amico 50,000 50,000 .85 $42,500
President and Chairman 500,000 500,000 .39 $195,000
STOCK OPTION PLANS
The Company provided a stock grant for its board of directors for 2004, as
described above under the heading entitled "Directors Compensation".
Other than as described above, the Company does not have any other form of
compensation payable to its officers or directors, including any stock option
plans, stock appreciation rights, or long term incentive plan awards for the
periods indicated in the table.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.
The following table identifies as of February 16, 2005 information regarding the
current directors and executive officers of the Company and those persons or
entities who beneficially own more than 5% of its common stock and Preferred
Stock of the Company, the number of and percent of the Company's common stock
beneficially owned by:
o all directors and nominees, naming them,
o our executive officers,
o our directors and executive officers as a group, without naming them, and o
persons or groups known by us to own beneficially 5% or more of our common
stock:
The Company believes that all persons named in the table have sole voting and
investment power with respect to all shares of common stock beneficially owned
by them.
A person is deemed to be the beneficial owner of securities that can be acquired
by him within 60 days from February 16, 2005 upon the exercise of options,
warrants or convertible securities. Each beneficial owner's percentage ownership
is determined by assuming that options, warrants or convertible securities that
are held by him, but not those held by any other person, and which are
exercisable within 60 days of February 16, 2005 have been exercised and
converted.
Peter Amico(1) Common Stock 1,870,623(6) 12.16%(2)
870B Central Avenue Preferred Stock 2,750,000(3)(5) 100%
Hammonton, NJ 08037
D. Barney Harris(1) Common Stock 236,025(7) 1.53%(2)
870B Central Avenue Preferred Stock 0 0%
Hammonton, NJ 08037
Frank Basile(1) Common Stock 142,873(8) *
870B Central Avenue Preferred Stock 0 0%
Hammonton, NJ 08037
James Hudson(1) Common Stock 75,800(9) *
870B Central Avenue Preferred Stock 0 0%
Hammonton, NJ 08037
William Hungerville(1) Common Stock 165,950(10) 1.07%(2)
870B Central Avenue Preferred Stock 0 0%
Hammonton, NJ 08037
All Officers and Directors Common Stock 2,491,271(11) 16.19%(2)
As a Group (5 persons) Preferred Stock 2,750,000 100%
11
Arcon Corp. Common Stock 1,580,623(4) 10.27%(2)
870B Central Avenue Preferred Stock 2,750,000(3)(5) 100%
Hammonton, NJ 08037
*Less than 1%
(1) The address of each beneficial owner is the address of the Company.
(2) Based on 15,387,092 shares of common stock outstanding as of February 16,
2005, except that shares of common stock underlying options or warrants
exercisable within 60 days of the date hereof are deemed to be outstanding for
purposes of calculating the beneficial ownership of securities of the holder of
such options or warrants.
(3) Based upon 275,000 outstanding shares of preferred stock after giving effect
to the 10 for 1 voting rights.
(4) Represents 1,580,623 shares held by Arcon Corp., a corporation wholly owned
by Mr. Amico ("Arcon"), and however, excludes common stock that may be issued to
Arcon as a dividend on the preferred stock.
(5) Represents shares held by Arcon.
(6) Represents 1,580,623 shares of common stock held by Arcon as stated in
footnote (4) above, and 305,000 shares of common stock held individually by Mr.
Amico.
(7) Represents 200,625 shares of common stock held individually, 25,000 shares
of common stock issuable under his employment agreement, and 5,000 shares of
common stock issuable upon exercise of director's options for 2002.
(8) Represents 100,000 shares held individually, 15,000 shares of common stock
issuable upon exercise under director's options for 2002 and 2001, 12,046 shares
held by an affiliate, and 10,000 shares held by his spouse. The amount excludes
shares of common stock to the Company's that may be granted to directors during
2004.
(9) Represents 41,300 shares of common stock held by an affiliate. The amount
excludes shares of common stock to the Company's that may be granted to
directors during 2004.
(10) Represents 34,300 shares of common stock held individually, 700 shares held
by his spouse and 10,000 shares held by a family trust. The amount excludes
shares of common stock to the Company's that may be granted to directors during
2004.
(11) Includes (4), (6), (7), (8), (9), and (10).
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.
Arcon Corp., a corporation wholly owned by the Company's chairman and president,
owns 275,000 shares of preferred stock of the Company. Each share of Preferred
Stock is entitled to 10 voting rights on all matters on which shareholders are
entitled to vote. The preferred stock has a stated value per share of $5.00 and
an annual dividend per share equal to 5% of the stated value. The annual cash
dividend as of November 31, 2004 was $68,750. Dividends are cumulative and the
holder has a right during any quarter to waive any cash dividend and receive the
dividend in the form of common stock at a price per share equal to 30% of the
lowest private offering or trading price of the common stock. The preferred
stock is not convertible into common stock, however, has a preference over
common stockholders upon liquidation equal to the stated value per share. For
fiscal year 2001, Arcon received 246,731 shares of common stock of the Company
in lieu of the cash dividend. For fiscal year 2002, Arcon received a cash
dividend of $17,187.50, and will receive 100,000 preferred shares in lieu of
221,892 shares of common stock of the Company in lieu of the cash payment for
the balance of the dividend. For fiscal year 2003, Arcon expects to receive
19,097 shares of common stock in lieu of the cash payment of the dividend. In
2004, Arcon received payments of $17,187.50 for dividends due in 2002,
$63,020.86 for dividends due in 2003 and $51,562.52 for dividends due in 2004,
of which $17,187.50 remains payable in accrued dividends to Arcon.
Arcon Corp. and the Company's President have made loans from time to time to the
Company in varying amounts. The loan is due on demand and bears interest at 12%.
As of December 31, 2004, the loan balance was $33,455.
Mrs. Patricia Amico, the wife of the Company's President, performed services to
the Company during 2004, 2003, 2002, and 2001 for which she received $13,030,
$11,579, $9,930, and $9,126, respectively.
12
Mr. Frank Basile, a director of the Company, is a partner of a law firm that
performed legal services to the Company during fiscal 2004, 2003 and 2002. The
billing amount for such services for each year was less than $10,000.
During 2002 and 2001, each director of the Company, other than Mr. Amico,
received a stock option to acquire 5,000 shares of common stock at a price per
share of $0.50, and in 2003, each director, other than Mr. Amico, received a
grant from the Company of 10,000 shares of common stock, and in 2004, each
director received a grant from the Company in the amount of 10,000 shares of
common stock.
13
ANNUAL REPORT OF THE COMPANY
A copy of the Company's Annual Report on Form 10-KSB for the year ended December
31, 2003 (the "Annual Report"), as amended, including financial statements,
accompanies this proxy statement. The Company filed its Annual Report on Form
10-KSB with the Securities and Exchange Commission on April 8, 2004.
Stockholders may obtain a copy of this report, without charge, by writing to:
Airtrax, Inc., 870B Central Avenue Hammonton, New Jersey 08037. In addition, the
Commission maintains a web site that contains reports, proxy and information
statements and other information regarding registrants that file electronically
with the Commission. The address of the Commission's web site is
http://www.sec.gov.
By Order of the Board of Directors,
/s/ Peter Amico
-----------
Peter Amico
Chief Executive Officer and Chairman
of the Board of Directors
Dated: March __, 2005
14
PROXY PROXY
AIRTRAX, INC.
PROXY FOR SPECIAL MEETING TO BE HELD ON MONDAY, MARCH 28, 2005
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints Peter Amico as proxy, with the power to
appoint his or her substitute, to represent and to vote all the shares of common
stock of Airtrax, Inc. (the "Company"), which the undersigned would be entitled
to vote, at the Company's Special Meeting of Stockholders to be held on March
28, 2005 and at any adjournments thereof, subject to the directions indicated on
the reverse side hereof.
In their discretion, the Proxies are authorized to vote upon any other
matter that may properly come before the meeting or any adjournments thereof.
THIS PROXY WILL BE VOTED IN ACCORDANCE WITH THE SPECIFICATIONS MADE,
BUT IF NO CHOICES ARE INDICATED, THIS PROXY WILL BE VOTED FOR THE PROPOSALS
LISTED ON THE REVERSE SIDE.
IMPORTANT--This Proxy must be signed and dated on the reverse side.
15
THIS IS YOUR PROXY
YOUR VOTE IS IMPORTANT!
Dear Stockholder:
We cordially invite you to attend a Special Meeting of Stockholders of
Airtrax, Inc. to be held on March 28, 2005 at 9:30 a.m. local time, at the
Ramada Inn, 2216 West Landis Avenue, Vineland, New Jersey 08360.
Please read the proxy statement which describes the proposals and presents
other important information, and complete, sign and return your proxy promptly
in the enclosed envelope.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR PROPOSALS 1, 2, 3 AND 4
1. Proposal to approve an amendment to the Company's certificate of
incorporation to increase the number of authorized shares of common stock
of the Company from 20,000,000 shares to 100,000,000 shares.
For Against Withheld
[ ] [ ] [ ]
2. Proposal to approve an amendment to the Company's certificate of
incorporation to increase the authorized shares of the Company's "blank
check" preferred stock from 500,000 to 5,000,000 shares.
For Against Withheld
[ ] [ ] [ ]
3. Proposal to approve an amendment to the Company's certificate of
incorporation to provide, to the fullest extent permitted by New Jersey
law, that the Company's directors or officers shall not be personally
liable to the Company or its shareholders for damages for breach of such
director's or officer's fiduciary duty.
For Against Withheld
[ ] [ ] [ ]
4. In their discretion, the Proxies are authorized to vote upon such other
business as may properly come before the Meeting.
For Against Withheld
[ ] [ ] [ ]
If you plan to attend the Special Meeting please mark this box [_]
Dated:____________________, 200___
Signature
------------------------------------------------------------------
Name (printed)
------------------------------------------------------------------
Title
------------------------------------------------------------------
Important: Please sign exactly as name appears on this proxy. When signing as
attorney, executor, trustee, guardian, corporate officer, etc., please indicate
full title.